title: The paraoxonase gene family and atherosclerosis.
abstract: Epidemiologic, genetic, and biochemical studies support an antiatherogenic role for paraoxonase (PON) 1. While the precise mechanism by which PON1 protects against the development of atherosclerosis is unclear, in vitro studies and the results from PON1 knockout and transgenic mice suggest that this protective effect may be attributed to PON1's ability to attenuate the oxidative modification of lipoprotein particles. The two other members of the PON gene family, namely, PON2 and PON3, have also been reported to possess antioxidant properties and may exhibit antiatherogenic capacities as well. Previous studies have demonstrated that PON1 expression is downregulated by oxidative stress. In contrast, more recent studies have shown that PON2 expression is upregulated in response to oxidative stress-inducing agents, while PON3 expression remains unchanged. While the physiological function of these proteins is unknown, studies currently underway using PON2 and PON3 knockout and transgenic mice should enable us to tease out the apparently redundant functions of these three proteins and yield clues as to their physiological function as well as their role in atherogenesis.
authors.affiliation: Atherosclerosis Research Unit, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
authors.forename: Carey J
authors.initials: CJ
authors.lastname: Ng
authors.forename: Diana M
authors.initials: DM
authors.lastname: Shih
authors.forename: Susan Y
authors.initials: SY
authors.lastname: Hama
authors.forename: Natividad
authors.initials: N
authors.lastname: Villa
authors.forename: Mohamad
authors.initials: M
authors.lastname: Navab
authors.forename: Srinivasa T
authors.initials: ST
authors.lastname: Reddy
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000235:genetics* / Q000473:pathology*; D043303:Aryldialkylphosphatase / Q000235:genetics* / Q000502:physiology*; D015536:Down-Regulation; D005260:Female; D005609:Free Radicals; D005838:Genotype; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D005810:Multigene Family; D018384:Oxidative Stress; D010100:Oxygen / Q000378:metabolism; D011110:Polymorphism, Genetic; D015854:Up-Regulation
chemical_list: D005609:Free Radicals; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D043303:Aryldialkylphosphatase; D010100:Oxygen